Before You Chase a Gap-Up, Measure What You Could Lose
MRNA gapped up 84% on Phase 3 results. Compare a gap-day-low stop, O’Neil’s 8% limit and a low-volume pullback entry, with share counts and risk.
Explore dated articles on Entry Execution, with worked examples, hypothetical decisions and research limitations.
MRNA gapped up 84% on Phase 3 results. Compare a gap-day-low stop, O’Neil’s 8% limit and a low-volume pullback entry, with share counts and risk.